Date Filed | Type | Description |
06/29/2023 |
4
| Moreno Toscano Jose Antonio (Director) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 123,795 shares
@ $0 |
|
06/29/2023 |
4
| LONGNECKER BRENT M (Director) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 123,795 shares
@ $0 |
|
06/29/2023 |
4
| Wilson William R Jr. (Director) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 123,795 shares
@ $0 |
|
04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2023 |
4
| VACZY CATHERINE M (EVP GC Chief Strategy Officer) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 245,000 shares
@ $0 |
|
02/22/2023 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 245,000 shares
@ $0 |
|
02/22/2023 |
4
| Kumar Hermant (Chief Mfgr & Tech Officer) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 200,000 shares
@ $0 |
|
02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/01/2022 |
4
| Confer Ryan M. (CFO) has filed a Form 4 on Genprex, Inc.
Txns:
| Exercised 116,973 options to buy
@ $0.015, valued at
$1.8k
|
|
07/29/2022 |
3/A
| Confer Ryan M. (CFO) has filed a Form 3/A on Genprex, Inc. |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2022 |
4
| Confer Ryan M. (CFO) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 341,750 options to buy
@ $2.2, valued at
$751.9k
|
|
02/08/2022 |
4
| Varner John Rodney (President & CEO) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 1,062,250 options to buy
@ $2.2, valued at
$2.3M
|
|
02/08/2022 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 98,750 options to buy
@ $2.2, valued at
$217.3k
|
|
02/08/2022 |
4
| Kumar Hermant (Chief Mfgr & Tech Officer) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 54,312 options to buy
@ $2.2, valued at
$119.5k
|
|
09/28/2021 |
4
| Kumar Hermant (Chief Mfgr & Tech Officer) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 400,000 options to buy
@ $2.85, valued at
$1.1M
|
|
09/28/2021 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 550,000 options to buy
@ $2.85, valued at
$1.6M
|
|
09/28/2021 |
3
| Kumar Hermant (Chief Mfgr & Tech Officer) has filed a Form 3 on Genprex, Inc. |
09/28/2021 |
3
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 3 on Genprex, Inc. |
06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/07/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
03/23/2021 |
4
| Confer Ryan M. (CFO) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 235,000 options to buy
@ $5.08, valued at
$1.2M
|
|
03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/23/2021 |
4
| Varner John Rodney (President & CEO) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 460,000 options to buy
@ $5.08, valued at
$2.3M
|
|
03/23/2021 |
4
| Redman Michael Thomas (EVP & COO) has filed a Form 4 on Genprex, Inc.
Txns:
| Granted 200,000 options to buy
@ $5.08, valued at
$1M
|
|
|